Sepsis News and Research

Latest Sepsis News and Research

New study describes economic consequences of using T2Candida Panel for detection of candidemia

A new study describes a model that estimates the economic consequences of using the T2Candida Panel (a novel diagnostic product that provides Candida detection) as an adjunct to the current blood culture-based diagnostic strategy in a high-risk hospital patient cohort.

9 Apr 2015

Babies with clinically suspected serious infections can be safely and effectively treated outside hospital

About 1 in 5 babies worldwide develop severe bacterial infections during the first month of life. These infections are responsible for around 700000 deaths in newborns every year...

6 Apr 2015

Amgen's Vectibix (panitumumab) receives EC approval for treatment patients with WT RAS mCRC

Amgen today announced that the European Commission approved a new use of Vectibix (panitumumab) as first-line treatment in combination with FOLFIRI for the treatment of adult patients with wild-type (WT) RAS metastatic colorectal cancer (mCRC).

6 Apr 2015

Outpatient treatments with fewer injections produce similar results to standard treatment course

Giving fewer antibiotic injections to young infants in the developing world with severe infections such as pneumonia and sepsis is just as safe and effective as the standard course of twice daily injections over the course of a week, according to new Johns Hopkins School of Public Health research conducted in Bangladesh.

6 Apr 2015

BP monitoring essential for early diagnosis, management of hypertensive disorders in pregnancy

Accurate blood pressure measurement (BP) is fundamental to the early diagnosis of hypertensive disorders in pregnancy, says a review published 1 April, 2015, in The Obstetrician & Gynaecologist (TOG).

3 Apr 2015

Hospira announces availability of INFLECTRA (infliximab) in Canada

Hospira, Inc., a global leader in biosimilars and the world's leading provider of injectable drugs and infusion technologies, announces the availability of INFLECTRA (infliximab) in Canada, the country's first subsequent entry biologic (SEB) monoclonal antibody (mAb) therapy.

30 Mar 2015

Experts call for global review of sepsis guidelines

Experts are calling for a global review of guidelines used to diagnose sepsis, after a study found one in eight patients with infections severe enough to need admission to an Intensive Care Unit in Australia and New Zealand, did not meet current criteria.

22 Mar 2015

Cardiovascular researchers identify MG53 protein necessary for repairing injured kidney cells

Cardiovascular researchers at The Ohio State University Wexner Medical Center have shown that a protein known as MG53 is not only present in kidney cells, but necessary for the organ to repair itself after acute injury. Results from this animal model study are published in the journal Science Translational Medicine.

19 Mar 2015

New research finds old blood just as good as fresh blood

Just like milk and many other foods, blood used for transfusions is perishable. But contrary to popular belief, new research shows that blood stored for three weeks is just as good as fresh blood - findings published today in the New England Journal of Medicine.

18 Mar 2015

Astute Medical hails launch of collaborative global initiative to prevent deaths from AKI by 2025

Astute Medical, Inc. today hailed the launch of a collaborative global initiative calling for the elimination of preventable deaths from acute kidney injury (AKI) by 2025. The Company cited the publication of a new Commission from The Lancet and the International Society of Nephrology, along with the release of results from the 0by25 AKI "Global Snapshot" study, as key steps forward in the effort to reduce the global burden of AKI.

17 Mar 2015

Rehospitalizations after severe sepsis may be potentially preventable

In an analysis of about 2,600 hospitalizations for severe sepsis, readmissions within 90 days were common, and approximately 40 percent occurred for diagnoses that could potentially be prevented or treated early to avoid hospitalization, according to a study in the March 10 issue of JAMA.

12 Mar 2015

United Therapeutics announces FDA approval of dinutuximab for treatment of high-risk neuroblastoma

United Therapeutics Corporation announced today that the United States Food and Drug Administration has approved Unituxin (dinutuximab) Injection (formerly called ch14.18), in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2), and 13-cis-retinoic acid (RA), for the treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to prior first-line multiagent, multimodality therapy.

10 Mar 2015

European launch of the Proxima miniature in-line blood gas analyser at ISICEM 2015

Sphere Medical, innovator in critical care monitoring and diagnostics equipment, will launch its ground-breaking in-line patient dedicated arterial blood gas analyser in Germany, Netherlands and Belgium at ISICEM 2015.

5 Mar 2015

Minihepcidin reverses iron overload of hemochromatosis, stops susceptibility to infections

Hemochromatosis (HH) is the most common genetic disorder in the western world, and yet is barely known. Only in the US 1 in 9 people carry the mutation (although not necessarily the disease).

2 Mar 2015

FDA approves LILETTA (levonorgestrel-releasing intrauterine system) to prevent pregnancy

Actavis plc, a leading global specialty pharmaceutical company, and Medicines360, a nonprofit women's health pharmaceutical company, today announced the approval of LILETTA (levonorgestrel-releasing intrauterine system) by the U.S. Food and Drug Administration for use by women to prevent pregnancy for up to three years.

27 Feb 2015

Trinity scientists reveal new marvel molecule that can block key process in inflammatory diseases

Scientists at Trinity College Dublin have uncovered a marvel molecule that blocks a key driver of inflammatory diseases. The finding could meet a major unmet clinical need by inspiring new non-invasive treatments for arthritis, multiple sclerosis and Muckle-Wells syndrome, among a myriad of other inflammatory diseases.

18 Feb 2015

UT Arlington chemist receives NIH's Academic Research Enhancement Award for protein research

A University of Texas at Arlington bio-analytical chemist exploring proteins, their structures and functions by using cutting-edge analytical instrumentation called mass spectrometry has received an Academic Research Enhancement Award from the National Institutes of Health.

18 Feb 2015

Sepsis News and Research

Latest Sepsis News and Research

New study describes economic consequences of using T2Candida Panel for detection of candidemia

Babies with clinically suspected serious infections can be safely and effectively treated outside hospital

Amgen's Vectibix (panitumumab) receives EC approval for treatment patients with WT RAS mCRC

Outpatient treatments with fewer injections produce similar results to standard treatment course

BP monitoring essential for early diagnosis, management of hypertensive disorders in pregnancy

Hospira announces availability of INFLECTRA (infliximab) in Canada

Experts call for global review of sepsis guidelines

Cardiovascular researchers identify MG53 protein necessary for repairing injured kidney cells

New research finds old blood just as good as fresh blood

Astute Medical hails launch of collaborative global initiative to prevent deaths from AKI by 2025

Rehospitalizations after severe sepsis may be potentially preventable

United Therapeutics announces FDA approval of dinutuximab for treatment of high-risk neuroblastoma

European launch of the Proxima miniature in-line blood gas analyser at ISICEM 2015

Minihepcidin reverses iron overload of hemochromatosis, stops susceptibility to infections

FDA approves LILETTA (levonorgestrel-releasing intrauterine system) to prevent pregnancy

Trinity scientists reveal new marvel molecule that can block key process in inflammatory diseases

UT Arlington chemist receives NIH's Academic Research Enhancement Award for protein research

UMHS opens Massey Emergency Critical Care Center

Hospira announces launch of first biosimilar monoclonal antibody in Europe

Great Basin Scientific begins clinical trial for Shiga toxin-producing E. coli diagnostic test

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Sepsis News and Research

Latest Sepsis News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in